<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04149093</url>
  </required_header>
  <id_info>
    <org_study_id>2020-2597</org_study_id>
    <nct_id>NCT04149093</nct_id>
  </id_info>
  <brief_title>The Association Between Calretinin and the Function of Ganglion Cells in Hirschsprung Disease</brief_title>
  <official_title>The Association Between Calretinin and the Function of Ganglion Cells in Long Segment and Total Hirschsprung Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Justine's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Justine's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to compare the outcomes of patients with long segment Hirschsprung disease or
      total colonic aganglionosis who had negative calretinin staining and positive ganglion cells
      on the proximal resection margins to those who had both positive findings.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2020</start_date>
  <completion_date type="Anticipated">December 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Long-term outcomes (Quality of life questionnaire)</measure>
    <time_frame>1 year</time_frame>
    <description>To determine if calretinin has a role in the function of ganglion cells in long segment Hirschsprung disease and total colonic aganglionosis.
HAQL (Hirschsprung's disease and Anorectal malformations Quality of Life) questionnaire. For each item the response is scored from 0 to 3 and then, linearly transformed to a 0 (minimum value) to 100 (maximum value) scale. Higher score suggests a better quality of life.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Surgical complications</measure>
    <time_frame>1 year</time_frame>
    <description>Number of reoperations
Number of rebiopsies
Number of readmissions
Number of bowel obstructions
Number of bowel perforation
Number of anastomotic leaks
Number of anastomotic strictures
Number of fistula
Number of anal stenosis
Number of Hirschsprung-associated enterocolitis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional outcomes</measure>
    <time_frame>1 year</time_frame>
    <description>Presence of constipation (yes/no)
Presence of diarrhea (yes/no)
Presence of incontinence and soiling (yes/no)
Presence of abdominal distension (yes/no)
Presence of dependance on enemas/medications (yes/no)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Hirschsprung Disease</condition>
  <condition>Ganglion</condition>
  <condition>Hirschsprung Disease, Long-Segment</condition>
  <condition>Hypoganglionosis</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Calretinin staining</intervention_name>
    <description>A paraffin-embedded hematoxylinphloxin-safran sections will be performed on tissue specimens of proximal resection margins to evaluate the presence or absence of ganglion cells.
Immunohistochemistry (IHC) will then be done on paraffin-embedded sections for calretinin staining.</description>
    <other_name>Immunohistochemistry</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Hirschsprung disease and a transition zone more proximal to the distal
        sigmoid
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Confirmed histopathological diagnosis of Hirschsprung disease from January 1, 1990 to
             August 31, 2019

          -  Long-segment Hirschsprung disease (type A and B)

          -  Total colonic aganglionosis (TCA)

          -  Surgery at CHUSJ

          -  Tissue blocks of proximal resection margin available for pathological analysis

          -  Minimum 1 month of postoperative follow-up

        Exclusion Criteria:

          -  Short-segment Hirschsprung disease (conventional form, rectosigmoid junction)

          -  Total colonic with small bowel aganglionosis (TCSA)

          -  Surgery done at another institution

          -  Early deaths

          -  Lost to follow-up

          -  No documented post-operative outcome
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>October 23, 2019</study_first_submitted>
  <study_first_submitted_qc>November 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 4, 2019</study_first_posted>
  <last_update_submitted>March 16, 2020</last_update_submitted>
  <last_update_submitted_qc>March 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>St. Justine's Hospital</investigator_affiliation>
    <investigator_full_name>Nelson Piche</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ganglion Cysts</mesh_term>
    <mesh_term>Synovial Cyst</mesh_term>
    <mesh_term>Hirschsprung Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

